drugset / Trial / NCT00624858
A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether a combination of naltrexone SR and bupropion SR is safe and effective in the treatment of major depression in overweight or obese subjects.
Timeline
- Start
- 2008-01
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 360 mg | — |
| Subject | Naltrexone | Small molecule | 32 mg | — |